French health authority gives green light to Nuvaxovid vaccine

Xinhua
15 Jan 2022, 03:35 GMT+10

PARIS, Jan. 14 (Xinhua) -- The French national authority of health (HAS) officially approved the Nuvaxovid vaccine for COVID-19 on Friday.

"The data from various studies shows the high efficiency of the Nuvaxovid vaccine against the symptomatic forms of COVID-19 (nearly 90 percent), and in particular against severe forms with nearly 100 percent efficiency," HAS said in a statement.

Nuvaxovid, manufactured by American biotechnology company Novavax, is suitable for people over the age of 18, with a delay between doses of three weeks, HAS said.

The health authority said the Novaxovid vaccine can be used for those who have not received any shots, or cannot receive the mRNA vaccines.

The French Ministry of Health has said that the first injections of Nuvaxovid can start in February, and it will receive 3.2 million doses for the first trimester. The first delivery of vaccines will arrive at the end of January.

The five COVID-19 vaccines authorized in France are Pfizer/BioNTech, Moderna, AstraZeneca, Janssen and Nuvaxovid.

The French government also allows those who have received two doses of the Chinese vaccines to obtain their health pass, on condition that they should receive a dose of an mRNA vaccine.

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to China National News.

More Information

null in null

Business

Section

Wall Street extends rally, Standard and Poor's 500 hits new high

NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...

Canadian tax on US tech giants dropped after Trump fury

WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...

Trump-backed crypto project gets $100 million boost from UAE fund

LONDON, U.K.: A little-known investment fund based in the United Arab Emirates has emerged as the most prominent public backer of U.S....

DIY weight-loss drug trend surges amid high prices, low access

SAN FRANCISCO, California: Across the U.S., a growing number of people are taking obesity treatment into their own hands — literally....

Apple allows outside payment links under EU pressure

SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...

Euro, pound surge as U.S. rate cut odds grow after Powell hint

NEW YORK CITY, New York: The U.S. dollar tumbled this week, hitting its lowest levels since 2021 against the euro, British pound, and...

Asia Pacific

Section